Results 201 to 210 of about 153,345 (297)
Four-Factor Prothrombin Complex Concentrate vs Plasma in Patients on Vitamin K Antagonists With Gastrointestinal Bleeding or Needing a Gastrointestinal Procedure: A Retrospective Analysis of 2 Randomized Controlled Trials. [PDF]
Refaai MA, Goldstein JN.
europepmc +1 more source
Characterization of amino‐terminal fragment liberated from bovine prothrombin by activated factor X
Takashi Morita+3 more
openalex +1 more source
Abstract Background and Objectives Viscoelastic haemostatic assays (VHA) are part of patient blood management (PBM) for bleeding, associated with reduced transfusions. This study reviewed all major haemorrhage protocols (MHPs) using VHA in Queensland, Australia, and assessed variability.
Akmez Latona+4 more
wiley +1 more source
Recombinant protein expression in <i>Acanthamoeba castellanii</i>. [PDF]
Salunke P, Kondabagil K, Karpe YA.
europepmc +1 more source
Preparation and Properties of Prothrombin
Estelle Zonderman+3 more
openaire +3 more sources
Pitfalls in Argatroban Monitoring: Heparin Interference With Dilute Thrombin Time Assays
International Journal of Laboratory Hematology, EarlyView.
Agathe Herb+3 more
wiley +1 more source
Characterization and management of patients with hereditary factor X deficiency: A case series
Abstract Background Hereditary factor X deficiency (HFXD) is an ultra‐rare, autosomal recessive bleeding disorder that results in reduced factor X coagulant activity (FX:C). HFXD is traditionally classified by severity as severe (FX:C <1%), moderate (FX:C = 1%–5%), or mild (FX:C = 6%–10%).
Meera Chitlur+4 more
wiley +1 more source